Shortage of Recombinant Coagulation Factor VIIa Resolved, FDA Says

August 06, 2024

A shortage of 8 milligram vials of Novo Nordisk’s NovoSeven RT coagulation factor VIIa (recombinant) that began in February is now resolved, according to an update from the Food and Drug Administration. The agency’s “CBER-Regulated Products: Resolved Shortages” web page reflects this resolution.